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Ras is a monomeric membrane-associated GTP-binding protein that regulates cell proliferation and survival in response to extracellular stimuli, such as activation of epi-
dermal growth factor receptor (EGFR) or T cell receptor (TCR). Originally identified as an oncogene in murine sarcoma viruses, activating mutations in Ras have been found 
in about 30% of human tumors. Dysregulation of the Ras signaling pathway plays a key role in the progression of cancer. When bound to GTP, Ras is active and stimulates 
several downstream targets by direct interactions. Ras has intrinsic GTPase activity, which can be activated by GTPase-activating proteins (GAPs) such as the NF1 tumor 
suppressor gene product and p120GAP. Activation of Ras occurs largely through guanine nucleotide exchange factors (GEFs) such as Sos and RasGRP1, which catalyze the 
exchange of Ras-bound GDP with free GTP. Multiple downstream effector pathways mediate Ras signaling, including the Raf/MEK/ERK kinase cascade, the PI 3-kinase/
Akt/mTor pathway, and the Ral GTPase pathway. Raf/MEK/ERK is the prototypical mitogen-activated protein kinase (MAPK) cascade, wherein each kinase phosphorylates 
and activates its downstream target, culminating in the activation of multiple targets including several transcription factors. Much of the recent work on the MAPK cascade 
has focused on negative feedback loops, such as the phosphorylation of Raf and Sos by ERK, as well as the transcription of negative regulators such as Sprouty and Spred. 
The second of the major downstream Ras targets, the PI 3-kinase/Akt/mTor pathway, contributes to cell growth, proliferation, and survival downstream of Ras. PI 3-kinase 
is a lipid kinase that phosphorylates phosphatidylinositol (4,5) bisphosphate (PIP2) to generate the second messenger phosphatidylinositol (3,4,5) trisphosphate (PIP3). PIP3 
activates Akt (PKB) and also GEFs for Rac GTPases, which regulate the actin cytoskeleton. Finally, Ras is able to activate another GTPase, Ral, through stimulation of the 
RalGDS family of guanine nucleotide exchange factors. Activation of Ral results in increased endocytosis and activation of the transcription factors Jun and Fos.
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